Tag: medulloblastoma research
-
Medulloblastoma drug effect only seen with molecular profiling
Modern molecular profiling of medulloblastomas recently highlighted a previously unrecognised treatment benefit in a major international clinical trial.
-
Molecular profiles show up clinical trial benefits
Research we funded has added value to a clinical trial that started in 2004. Updated scientific techniques showed that some children with a medulloblastoma can safely be spared harmful treatments.
-
New breakthrough into Medulloblastoma
Researchers from St. Jude Children’s Research Hospital in the US and the German Cancer Research Centre have discovered faulty genes underlying medulloblastoma brain tumours.
-
New insight into medulloblastoma
The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.
-
Gene-editing techniques give new insight on key protein involved in medulloblastoma development
Researchers at St. Jude Children’s Research Hospital, USA have revealed how a key protein involved in driving the growth of the most aggressive form of medulloblastoma also plays a role in stopping its development.
-
American researchers explore cell enzyme as a potential paediatric brain tumour treatment
Researchers from the University of North Carolina Health Care System have been exploring the role of a DNA repair enzyme in cells called Dicer. When they removed this enzyme from preclinical models of medulloblastoma, a brain cancer often found in children, they found increased levels of DNA damage that led to the cell’s death.